ChemoCentryx
CCXI
#3654
Rank
NZ$6.80 B
Marketcap
NZ$94.63
Share price
0.00%
Change (1 day)
37.63%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): NZ-$2.81

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is NZ-$3.44. In 2021 the company made an earnings per share (EPS) of NZ-$3.44 a decrease over its 2020 EPS that were of NZ-$1.47.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ-$2.81-18.27%
2021NZ-$3.44133.33%
2020NZ-$1.47-16.49%
2019NZ-$1.7727.63%
2018NZ-$1.38-305.41%
2017NZ$0.67-142.53%
2016NZ-$1.58-19.44%
2015NZ-$1.97-0%
2014NZ-$1.9713.68%
2013NZ-$1.73-16.67%
2012NZ-$2.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.16-453.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.29-137.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$10.65-409.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.63-1,019.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$4.30-224.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.81-152.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.23-339.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.24-252.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$0.82-123.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel